Wednesday, 6 December 2017

FDA Grants IND of ARTEMIS™ T cell Platform To Enhance CAR-T Cancer Therapies Without Cytokine Storm

  1. FDA Grants IND of ARTEMIS™ T cell Platform To Enhance CAR-T Cancer Therapies Without Cytokine Storm  MedicalResearch.com (blog)Full coverage
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)